Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lauren Flynn Kelly

Latest From Lauren Flynn Kelly

Medicare Part D Sponsors Grapple With Unknowns As Drug Price Negotiations Begin

CMS will monitor Medicare plans’ use of utilization management, and they are required to have the negotiated drugs on formulary, but the ‘ultimate question’ is how the plans will cover these negotiated drugs.

Medicare Reimbursement

IRA Changes Will Drive Up Medicare Part D Plan Bids in 2024, But Premiums Will Stabilize

CMS now supporting the basic premium more because IRA-related improvements have reduced the need for additional benefit enhancements traditionally offered by enhanced alternative Part D plans.

Medicare Reimbursement
See All